Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

Generative AI technology has tremendous potential for the healthcare industry, but we shouldn’t expect too much – especially if we’re the FDA.

Kennedy, Jr. as a revolutionary solution for shortening drug approvals — is initially causing more hallucinations than solutions. Known as Elsa, the AI chatbot was introduced to help FDA employees ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug approvals. As CNN reports, six current and former FDA officials are warning that ...

While the FDA is not commenting about how far it might use AI tools in speeding up the drug and device review process, some experts say that the agency so far seems to be focusing on ...

U.S. Food and Drug Administration employees told CNN that Elsa — the AI model that’s supposed to help speed up approvals of pharmaceuticals and medical devices — isn’t working great. Instead, it cites ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump administration invests in even more automation amid thousands of federal ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump administration invests in even more automation amid thousands of federal ...

WASHINGTON, D.C. — The Food and Drug Administration is planning to use artificial intelligence to “radically increase efficiency” in deciding whether to approve new drugs and devices, one of ...

The U.S. Food and Drug Administration (FDA) has introduced “Elsa,” a generative AI tool designed to enhance the efficiency of its regulatory operations.

Despite its well-publicised problems, the US FDA is a happy place for ASX biotechs seeking drug or device approvals. ... Read ...

It takes the FDA an average of 10 months to review a new drug and six to nine months to review a high-risk device, such as a pacemaker or heart valve.